Pharmacology and Toxicology Research
Associate Dean for Research; Professor; Director, Neuroscience Research Center; G. Frederick Kasten, Jr. Endowed Chair in Parkinson’s Disease Research
Recent NewsSee All News
Study Looks at Use of Mitochondria-Targeted Malaria Drug to Prevent Tumor Growth and Dissemination
March 14, 2022
Balaraman Kalyanaraman, PhD, chair and professor of biophysics and the Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research, collaborates with researchers at the Medical College of Wisconsin, Houston Methodist Research Institute, and Aix-Marseille Université.
Dr. Kirk Pritchard Receives Grant Renewal to Continue Work to Improve Vascular Function in People with Sickle Cell Disease
April 30, 2021
Kirkwood Pritchard, PhD, has been awarded a four-year, $2.2 million R01 grant renewal for the project titled, “Mechanisms of Inflammation in Sickle Cell Disease” from the National Heart, Lung, and Blood Institute.
MCW Researchers are Inventors on Newly Awarded U.S. Patent for Mito-Honokiol Compounds and Methods to Treat Cancer
December 3, 2020
Medical College of Wisconsin (MCW) researchers led a team that invented the technology in MCW’s recently awarded U.S. Patent 10,836,782 for Mito-Honokiol Compounds and Methods of Synthesis and Use Thereof.
Unlocking the Therapeutic Potential of Medical Cannabis
December 17, 2019
On November 14, the Medical College of Wisconsin School of Pharmacy hosted a professional development seminar focusing on medical cannabis. The seminar provided an overview of the therapeutic potential of medical cannabis.
Dr Qing-song Liu Receives Three RO1 Grants to Continue His Research on Mechanisms of Cocaine Addiction, Anxiety
October 4, 2019
These RO1 grants will support Dr. Liu's ongoing research into aspects of cocaine addiction and the impact of endocannabinoid signaling on stress.
MCW researchers publish collaborative study on potential intervention for lung cancer brain metastasis
July 10, 2019
A collaborative research team from MCW, the University of Michigan, and Aix-Marseille University has a potential new intervention for lung cancer brain metastasis that has little toxicity in a mouse model.